Showing results (131-140 of 382) with videos related to

Sort By:
Pageof 39
Blood|June 19, 2008
Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cellsWinnie F Tam, Ting-Lei Gu, Jing Chen, et al.
BMC Genomics|September 13, 2014
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotypeSimone Feurstein, Frank G Rücker, Lars Bullinger, et al.
World Neurosurgery|March 15, 2017
Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of LifeLinda Stöckelmaier, Mirjam Renovanz, Jochem König, et al.
Blood Advances|April 29, 2022
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplicationsHartmut Döhner, Daniela Weber, Julia Krzykalla, et al.
BMC Cancer|January 31, 2020
Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experienceJana Käthe Striefler, Franziska Brandes, Alexander Baur, et al.
Cancer Medicine|March 17, 2022
Comorbidities rather than older age define outcome in adult patients with tumors of the Ewing sarcoma familyJana Käthe Striefler, Maren Schmiester, Franziska Brandes, et al.
Haematologica|November 4, 2005
Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemiaMichael Heuser, Luzie U Wingen, Doris Steinemann, et al.
Nature|November 17, 2017
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Nature|August 3, 2018
Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Pageof 39